Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis
Authors:
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 2 (4) , 100246
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation
- Crown Human Genome Center
- Masonic Charitable Foundation
- European Research Council
- Else Kröner-Fresenius-Stiftung
- Minerva Foundation
This publication has 123 references indexed in Scilit:
- The GEM mapper: fast, accurate and versatile alignment by filtrationNature Methods, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosisScientific Reports, 2011
- Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerveProceedings of the National Academy of Sciences, 2011
- Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)Proceedings of the National Academy of Sciences, 2011
- Normal gut microbiota modulates brain development and behaviorProceedings of the National Academy of Sciences, 2011
- Differential diagnosis of suspected multiple sclerosis: a consensus approachMultiple Sclerosis Journal, 2008
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000
- Rating neurologic impairment in multiple sclerosisNeurology, 1983